Search research articles
Contact Us
Filters
Showing results (11-20 of 26) with videos related to
Page
of 3
Sort By:
The Oncologist
|
April 7, 2023
External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort
Maxime Frelaut, Elena Paillaud, Guillaume Beinse, et al.
The Journal of Nutrition, Health & Aging
|
March 22, 2024
Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study
Catherine Conti, Elena Paillaud, Marie Laurent, et al.
JAMA Network Open
|
September 10, 2025
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer
Adrien Rousseau, Noémie Simon-Tillaux, Stefan Michiels, et al.
Cancer Medicine
|
November 8, 2023
Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study (ELCAPA-19)
Déborah Assouan, Elena Paillaud, Philippe Caillet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Non-Small Cell Lung Cancer (NSCLC) in Vulnerable and Special Populations: Towards Personalized Care
Claudia Parisi, Andrea De Giglio, Marco Banini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 9, 2023
Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Adrien Rousseau, Marco Tagliamento, Edouard Auclin, et al.
Nutrients
|
March 11, 2023
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
Anne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, et al.
Journal of Geriatric Oncology
|
May 21, 2023
Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study
Sébastien Gendarme, Sonia Zebachi, Romain Corre, et al.
JAMA Oncology
|
April 9, 2026
Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received Pembrolizumab
Adrien Rousseau, Stéphanie Foulon, David Planchard, et al.
JCO Precision Oncology
|
January 7, 2022
Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)
Grégoire Marret, Ivan Bièche, Célia Dupain, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 26) with videos related to
Sort By:
Page
of 3
The Oncologist
|
April 7, 2023
External Validity of Two Scores for Predicting the Risk of Chemotherapy Toxicity Among Older Patients With Solid Tumors: Results From the ELCAPA Prospective Cohort
Maxime Frelaut, Elena Paillaud, Guillaume Beinse, et al.
The Journal of Nutrition, Health & Aging
|
March 22, 2024
Prognostic impact of neurocognitive disorders in older patients with cancer: the ELCAPA prospective cohort study
Catherine Conti, Elena Paillaud, Marie Laurent, et al.
JAMA Network Open
|
September 10, 2025
Concomitant Comedications and Survival With First-Line Pembrolizumab in Advanced Non-Small-Cell Lung Cancer
Adrien Rousseau, Noémie Simon-Tillaux, Stefan Michiels, et al.
Cancer Medicine
|
November 8, 2023
Cancer mortality and competing causes of death in older adults with cancer: A prospective, multicentre cohort study (ELCAPA-19)
Déborah Assouan, Elena Paillaud, Philippe Caillet, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
April 1, 2026
Non-Small Cell Lung Cancer (NSCLC) in Vulnerable and Special Populations: Towards Personalized Care
Claudia Parisi, Andrea De Giglio, Marco Banini, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 9, 2023
Clinical outcomes by infusion timing of immune checkpoint inhibitors in patients with advanced non-small cell lung cancer
Adrien Rousseau, Marco Tagliamento, Edouard Auclin, et al.
Nutrients
|
March 11, 2023
Pre-Therapeutic Sarcopenia among Cancer Patients: An Up-to-Date Meta-Analysis of Prevalence and Predictive Value during Cancer Treatment
Anne-Laure Couderc, Evelyne Liuu, Pascaline Boudou-Rouquette, et al.
Journal of Geriatric Oncology
|
May 21, 2023
Predictors of three-month mortality and severe chemotherapy-related adverse events in patients aged 70 years and older with metastatic non-small-cell lung cancer: A secondary analysis of ESOGIA-GFPC-GECP 08-02 study
Sébastien Gendarme, Sonia Zebachi, Romain Corre, et al.
JAMA Oncology
|
April 9, 2026
Outcomes and Treatments of Patients With Non-Small Cell Lung Cancer Who Received Pembrolizumab
Adrien Rousseau, Stéphanie Foulon, David Planchard, et al.
JCO Precision Oncology
|
January 7, 2022
Genomic Alterations in Head and Neck Squamous Cell Carcinoma: Level of Evidence According to ESMO Scale for Clinical Actionability of Molecular Targets (ESCAT)
Grégoire Marret, Ivan Bièche, Célia Dupain, et al.
Page
of 3